RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.

about

Risk of gastrointestinal events with newly approved (after 2011) vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a meta-analysis of randomized controlled trials.

P2860

Q38678038-EF30CCDD-0A80-4A07-9FCA-1C54D8A46E28

P2860

RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.

Item

http://www.wikidata.org/entity/Q38973621

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

RADVAN: a randomised phase 2 t ...... - results and lessons learnt.

@en

type

Item

label

RADVAN: a randomised phase 2 t ...... - results and lessons learnt.

@en

prefLabel

RADVAN: a randomised phase 2 t ...... - results and lessons learnt.

@en

P1476

RADVAN: a randomised phase 2 t ...... - results and lessons learnt.

@en

P2093

Adelyn Wise

http://www.w3.org/2001/XMLSchema#string

Amanda Salisbury

http://www.w3.org/2001/XMLSchema#string

Avinash Gupta

http://www.w3.org/2001/XMLSchema#string

Carie Corner

http://www.w3.org/2001/XMLSchema#string

Charles Kelly

http://www.w3.org/2001/XMLSchema#string

Corran Roberts

http://www.w3.org/2001/XMLSchema#string

Ernie Marshall

http://www.w3.org/2001/XMLSchema#string

Finn Tysoe

http://www.w3.org/2001/XMLSchema#string

James Lester

http://www.w3.org/2001/XMLSchema#string

Jenny Nobes

http://www.w3.org/2001/XMLSchema#string

P2860

Interim results in clinical trials: do we need to keep all interim randomised clinical trial results confidential?

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?

Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases.

Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts.

A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).

Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.

Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases.

Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma.

Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study.

P2888

bjc.2016.318

P304

1193-1200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2016.318

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012524195

http://www.w3.org/2001/XMLSchema#string

P698

27711083

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

5104891

http://www.w3.org/2001/XMLSchema#string

RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.

about

P2860

P2860

RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P921

P932